Omalizumab-induced paradoxical urticaria responsive to dupilumab

Ann Dermatol Venereol. 2023 Sep 7:S0151-9638(23)00068-6. doi: 10.1016/j.annder.2023.06.007. Online ahead of print.NO ABSTRACTPMID:37689535 | DOI:10.1016/j.annder.2023.06.007

Source: Annales de Dermatologie et de Cenereologie - September 9, 2023 Category: Dermatology Authors: A-C Fougerousse A Badaoui Source Type: research